These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 3930749

  • 1. Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease.
    Chandy KG, Pahl M, Vaziri ND, Gupta S.
    J Clin Lab Immunol; 1985 Jul; 17(3):119-24. PubMed ID: 3930749
    [Abstract] [Full Text] [Related]

  • 2. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
    Raskova J, Ghobrial I, Shea SM, Ebert EC, Eisinger RP, Raska K.
    Diagn Immunol; 1986 Jul; 4(4):209-16. PubMed ID: 2944684
    [Abstract] [Full Text] [Related]

  • 3. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.
    Raskova J, Ghobrial I, Czerwinski DK, Shea SM, Eisinger RP, Raska K.
    Arch Intern Med; 1987 Jan; 147(1):89-93. PubMed ID: 3492183
    [Abstract] [Full Text] [Related]

  • 4. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P.
    J Immunol; 1995 Jan 15; 154(2):882-92. PubMed ID: 7814891
    [Abstract] [Full Text] [Related]

  • 5. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
    Kleiman KS, Zoschke DC.
    J Lab Clin Med; 1985 Sep 15; 106(3):262-8. PubMed ID: 3928781
    [Abstract] [Full Text] [Related]

  • 6. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G, Mandrekar P, Dolganiuc A, Catalano D, Kodys K.
    Alcohol Clin Exp Res; 2001 Dec 15; 25(12):1766-72. PubMed ID: 11781510
    [Abstract] [Full Text] [Related]

  • 7. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
    Smith MD, Hardy G, Williams JD, Coles GA.
    Clin Nephrol; 1983 Sep 15; 20(3):130-5. PubMed ID: 6226465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 15; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 10. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb 15; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G, Kher V, Naik S.
    Scand J Urol Nephrol; 2002 Feb 15; 36(5):377-82. PubMed ID: 12487744
    [Abstract] [Full Text] [Related]

  • 13. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
    Altun B, Erdem Y, Usalan C, Arici M, Haznedaroglu IC, Yasavul U, Turgan C, Caglar S, Kirazli S.
    Clin Nephrol; 1999 Oct 15; 52(4):230-8. PubMed ID: 10543325
    [Abstract] [Full Text] [Related]

  • 14. Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
    Nanishi F, Inenaga T, Onoyama K, Oh Y, Oochi N, Fujishima M.
    J Clin Lab Immunol; 1986 Apr 15; 19(4):167-74. PubMed ID: 2941588
    [Abstract] [Full Text] [Related]

  • 15. The effect of hemodialysis on lymphocyte subsets during dialysis.
    Chida Y, Sakurai S, Yoshiyama N.
    Clin Nephrol; 1986 Mar 15; 25(3):159-64. PubMed ID: 3754188
    [Abstract] [Full Text] [Related]

  • 16. Defective lymphoproliferative responses & interleukin-2 production in chronic renal failure patients.
    Krishnamurthy G, Kher V, Naik S.
    Indian J Med Res; 1995 Dec 15; 102():281-6. PubMed ID: 8557322
    [Abstract] [Full Text] [Related]

  • 17. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T, Osono E, Hayama N, Lino Y, Terashi A.
    Clin Nephrol; 1997 Dec 15; 48(6):353-8. PubMed ID: 9438093
    [Abstract] [Full Text] [Related]

  • 18. [The ratio of the T lymphocyte subpopulation in patients on chronic hemodialysis].
    Ljaljević J, Savin S, Veljović R, Ostrić V, Zlatković Lj.
    Glas Srp Akad Nauka Med; 1985 Dec 15; (37):109-16. PubMed ID: 3879872
    [No Abstract] [Full Text] [Related]

  • 19. T mediated immunity in patients undergoing periodic hemodialysis.
    Piazza I, Alibrandi F, Semenzato G, Battistella L, Amadori G, Gasparotto G.
    Boll Ist Sieroter Milan; 1978 Nov 30; 57(5):631-6. PubMed ID: 314813
    [Abstract] [Full Text] [Related]

  • 20. Impaired T cell proliferation in acute dengue infection.
    Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL.
    J Immunol; 1999 May 01; 162(9):5609-15. PubMed ID: 10228044
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.